11-64727354-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_001098671.2(RASGRP2):c.1778G>A(p.Arg593His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000778 in 1,613,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R593C) has been classified as Likely benign.
Frequency
Consequence
NM_001098671.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RASGRP2 | NM_001098671.2 | c.1778G>A | p.Arg593His | missense_variant | 16/17 | ENST00000394432.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RASGRP2 | ENST00000394432.8 | c.1778G>A | p.Arg593His | missense_variant | 16/17 | 1 | NM_001098671.2 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.000460 AC: 70AN: 152110Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000314 AC: 79AN: 251380Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135882
GnomAD4 exome AF: 0.000811 AC: 1186AN: 1461654Hom.: 0 Cov.: 31 AF XY: 0.000751 AC XY: 546AN XY: 727132
GnomAD4 genome ? AF: 0.000460 AC: 70AN: 152228Hom.: 0 Cov.: 31 AF XY: 0.000390 AC XY: 29AN XY: 74438
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 20, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 19, 2022 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 593 of the RASGRP2 protein (p.Arg593His). This variant is present in population databases (rs149482849, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with RASGRP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 594472). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.1778G>A (p.R593H) alteration is located in exon 16 (coding exon 15) of the RASGRP2 gene. This alteration results from a G to A substitution at nucleotide position 1778, causing the arginine (R) at amino acid position 593 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at